Short term efficacy evaluation: the success rate of phase reduction and tumor necrosis rate (≥ 50%) were compared between group A and group B. Long term prognosis evaluation: the recurrence free survival rate and overall survival rate of "bridging" treatment group and non bridging treatment group were compared respectively. The recurrence rate, recurrence free survival rate and overall survival rate of group A, group B and group C were compared. The recurrence free survival rate and overall survival rate were compared between the two groups with tumor necrosis rate ≥ 50% and tumor necrosis rate < 50%. The relapse free survival rate and overall survival rate were compared between the successful group and the unsuccessful group.
正在翻译中..